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CObjectives: To develop a coherent method for estimating mappings
between treatment effects on disease-specific measurement (DSM) in-
struments and generic health-related quality-of-life (QOL) measures,
when both are subject tomeasurement errors. Methods: We identified
hree properties that must be satisfied for mappings to be logically
oherent: invertability, transitivity, and invariance to linear transfor-
ation. Of the common regressions, ordinary least squares (OLS), geo-
etric mean (GM), and orthogonal regression, only GM has all these
roperties, and then only in special cases. We developed a common
actor model of how DSM and generic QOL scales are related, and de-
ived expressions for coherent mapping coefficients. We showed that
hese are equivalent to adjusted forms ofOLS or GM regressions.Where
ohort data are available on just one DSM and one QOL measure, ex-
ernal data on the reproducibility of the DSM are required. In some
ircumstances, the mappings can be estimated without external data.
e illustrated the estimation of mapping coefficients by using data on O
mun
al So
ttp://dx.doi.org/10.1016/j.jval.2012.07.003uroQol five-dimensional (EQ-5D) questionnaire, 12-item short form
ealth survey (SF-12) Mental Component Summary, and the Beck De-
ression Inventory (BDI), from a trial of treatments for depression.
esults: OLS underestimates and GM overestimates mappings from
SMs to generic QOL measures. Mappings estimated by using external
ata on reliability were similar to those estimated by using internal
ata, suggesting approximate adequacy of the common factor model.
onclusions: Neither OLS nor GM regression, unless corrected, is suit-
ble for estimating mappings between disease-specific and generic
OL scales. OLS systematically underestimatesmappings, but it can be
djusted by using external information on test-retest reliability.
eywords: Beck Depression Inventory, common factor model, EQ-5D,
apping, measurement error, SF-12.
opyright © 2013, International Society for Pharmacoeconomics and
utcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Assessment of health interventions is based primarily on a syn-
thesis of evidence from randomized controlled trials and cost-
effectiveness analysis (CEA). The CEA is often based on generic
health-related quality-of-life (QOL) measures, such as EuroQol
five-dimensional (EQ-5D) questionnaire or the health utility index,
because this allows decision makers to consider all interventions
on a common scale. Randomized controlled trials, however, sel-
dom report treatment effects on these generic instruments. Even
though the role of generic scales in decision making is becoming
well established, trialists continue to use disease-specific measures
(DSMs) asprimaryendpoints in trials inpreference toadirect assess-
ment of generic QOL measure, as the former often tend to be more
sensitive to changes in outcome due to treatment, and hence more
likely to yield a statistically robust effect [1,2]. As a result, there is a
need for an accurate and reliable method for translating treatment
effectsmeasured ondisease-specific scales into treatment effects on
a generic QOL scale. This is called “mapping”: treatment effects esti-
mated on theDSMaremultiplied by amapping coefficient to convert
them into treatment effect estimates on the generic QOL scale [3–5].
This article is an inquiry into what properties mapping coefficients
should have and how they should be estimated.
* Address correspondence to:Guobing Lu, School of Social andCom
ristol BS8 2PS, UK.
E-mail: Guobing.Lu@bristol.ac.uk.
098-3015/$36.00 – see front matter Copyright © 2013, Internation
ublished by Elsevier Inc.Mapping can be seen as a form of calibration. This article looks
at the simplest case, a univariate mapping in which a single coef-
ficient is used to map from one scale to another. Typically, the
coefficient is a regression coefficient estimated in studies inwhich
patients with the condition of interest have been measured on
both the DSM and the generic quality-adjusted life-year measure.
These are usually observational cohort studies rather than trials.
Once the mapping coefficient is estimated, it can be used to map
treatment effects on DSMs to treatment effects on generic HRQOL
instruments in trials in which these have not been used.
Ordinary least squares (OLS) regression of the generic QOL
against the DSM is by far the most common method [5] used to
obtain amapping coefficient. In this article, we argue that OLSwill
underestimate the correct mapping, because it does not take ac-
count of the measurement error in the DSM. All DSMs, whether
patient- or clinician-reported, are known to suffer from measure-
ment error: assessment of test-retest reliability (TRR) and interra-
ter reliability is part of their validation, and reliability values, typ-
ically ranging from 0.60 to 0.85, are routinely reported in standard
texts [6,7] and on the official Web sites for the test instruments.
The objective of this article was to develop a new approach to
mapping that takes measurement error into account and to com-
pare results to OLS, and other regressions, in an illustrative exam-
ple. We focus throughout on the familiar situation in which an
ityMedicine, University of Bristol, CanyngeHall, 39Whatley Road,
ciety for Pharmacoeconomics and Outcomes Research (ISPOR).
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178 V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4estimate of the treatment effect is available, but only on the DSM
scale. An estimate of the treatment effect on a generic QOL scale is
required for CEA, and external data in the form of a cohort study
are available fromwhich amapping from DSM to generic QOL can
be derived.We begin by proposing a series of key criteria thatmust
bemet if mappings are to be considered “coherent” in a sense that
will be explained below. We then summarize the features of the
three forms of regression—OLS, geometricmean (GM), and orthog-
onal regression (OR)—and show that only GM regression [8] can
satisfy all the desired criteria.We develop a structural equation, or
“common factor” model, of how DSMs and generic QOLs are re-
lated.We show how coherentmapping coefficients can be derived
from this model, and how they represent adjusted versions of the
OLS and GM coefficients. We illustrate the differences between
alternative regressions and their different properties with a trial
data set looking at mappings between the Beck Depression Inven-
tory [9], a disease-specificmeasure, and two genericmeasures, the
SF-12 Mental Components Summary (SF-12M) and the EQ-5D
questionnaire. We estimate a set of coherent mappings for these
scales by using a trial cohort, in two ways. In the Discussion sec-
tion, we examine the adequacy of the assumptions made, the de-
gree of underestimation in mapping estimates based on OLS, and
how to adjust published OLS estimates, and the possible applica-
tion of evidence synthesis techniques to combine the many
sources of information that bear on mapping coefficients.
A companion article in this volume [10] uses the sameunderlying
model to consider a related question: given that an estimate of the
treatment effect on a generic QOL scale is needed for economic as-
sessment, is it best tomeasure the treatment effect on a generic QOL
instrument when designing a trial, or should one estimate the treat-
ment effect byusingaDSMand thenmap this onto thegeneric scale?
Methods
Properties of a coherent mapping
We shall use the notation X→Y to denote a mapping coefficient
rom a measurement instrument X to another instrument Y. The
appings are intended to “convert” treatment effects, such as
hose estimated in randomized trials, from one scale to another.
hus, if the effect of a treatment measured on instrument X is ,
hen this is equivalent to an effect X→Y on Y. On the basis of
common sense” and logic, we propose three key properties that
re required if a mapping system is to be considered coherent.
Invertability: X→Y  1⁄Y→X
The mapping coefficient for Y ¡ X must be the reciprocal of the
mapping coefficient for X¡ Y. In other words, if we map one way,
hen we can invert the process and end up where we started. No
apping could be regarded as coherent if this were not the case.
he requirement is perhaps connected to a wider need for symme-
ry, such that we no longer differentiate between dependent and
ndependent variables. Such a requirement results in a unique
olution regardless of the direction of mapping [11,12].
It might be objected that this is unimportant in practice as we
lwaysmap in just one direction, from disease-specific scores to a
eneric QOL measure. Even so, it is obvious that if a treatment
ffect of size x on a DSM is equivalent to an effect of size y on a
OL, then y on the QOL is equivalent to x on the DSM. Clearly, only
n invertible mapping can make sense.
Transitivity: X→Z  X→YY→Z
If there are three scales X, Y, and Z, we should get the same result
hether we map X¡Z or whether we first map X¡Y and then
¡Z. For example, wemayhave a single data set inwhich all three
utcomes are measured. Once again, it might be objected that in ipractice one can map from one DSM-1 to DSM-2 and then DSM-2
from the EQ-5D questionnaire without any “need” to require tran-
sitivity. A data set in which all three measures had been recorded,
however,would allowone to estimatemappings both fromDSM-1 to
the EQ-5D questionnaire and from DSM-2 to the EQ-5D question-
naire. But itwouldbevery strange if thesewere inconsistentwith the
mapping from DSM-1 to DSM-2, which we would have estimated
(directly) if the EQ-5D questionnaire had by chance not been re-
corded! Transitivity is required for coherence, just as invertability is.
Scaleinvariance: If X→Y fX,Y,thenfc1X,c2Yc1⁄c2f
X, Y for any scalars c1, c2  0
This requirement ensures that linear changes of scale can be car-
ried through appropriately to changes in the coefficients. For ex-
ample, if we were mapping from the BDI scale to the EQ-5D ques-
tionnaire, if we divided the BDI measurements by 10, we would
want the newmapping coefficient to be 10 times the previous one.
Three types of regression
It is immediately clear that OLS regressionwill not produce coherent
mappings, because ˆX→Y
OLS  ˆY→XOLS 1. Two other forms of regres-
sion—GM regression and OR [8]—are of potential interest, as both
have thesymmetryproperty (Fig. 1).WhileOLSminimizes thesumof
squaredvertical distances fromthe lineand inverseOLS thehorizon-
tal, ORminimizes the sumof squared distances perpendicular to the
line, while GM minimizes the sum of the areas of the right angle
triangles subtended from the line [8,13]. OR, however, is not scale
invariant and will not be discussed further. The relation between GM
andOLS regressions and coherentmapping is discussed further below.
A commonly used criterion for the choice of regression is the
accuracy of prediction of individual scores on one scale given
scores on the other. This is not a major concern in this article, in
which our intention is to map mean treatment effects. But, in any
case, the criteria for “accuracy of prediction,” that is, best fit, are
based on themodel assumed for error, as shown in Figure 1. Model
choice cannot therefore be based on prediction accuracy, as its
definition depends on the model.
A common factor model of test instruments
We focus specifically on mappings from single disease-specific
instruments to generic QOL instruments. Suppose we have a dis-
ease-specific test instrument on depression Y (say BDI) and a ge-
neric QOL instrument Q (e.g., the EQ-5D questionnaire). We imag-
ine a cohort study j on “depressed” individuals i,with observations
on both Y and Q. Consider the following single common factor model:
Yij a1j b1jyijh11ij,
Qij a2j b2jyij fjxijh22ij,
where xij, yij, 1ij, 2ij indN(0, 1)
(1)
The variable y represents a common “depression” factor in both Y
and Q and 1 and 2 are the measurement error in the Y and Q
measures, respectively. The interpretation of “measurement er-
ror” that we intend is anything that threatens the reproducibility
of the test. The variable x represents the orthogonal “nondepres-
sion” component specific to theQ instrument.We assume that the
four variables are uncorrelated. The coefficients b1j,b2j,h1,h2,fj are
the “factor loadings.” Note that except for themeasurement errors,
which are seen as intrinsic properties of the test instruments, the
factor loadings are indexed by study j. This indicates that different
populations of “depressed” patients can be sampled in different
studies, and these populations may have different variances.
Note that model (1) implies all three coherence properties. An
intervention that causes a unit change in the depression factor y
will lead to an expected b change in Y and an expected b change1j 2j
n Q. This tells us that the appropriate mapping must be Y→Q 
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179V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4b2j⁄b1j. By the same argument, we also obtain the inverse mapping
as Q→Y b1j⁄b2j, showing that the parameter conceptualized in this
ay is invertible. By creating a third testwith coefficients a3 and b3,
and by introducing linear transformations, it can be further easily
verified that the resulting mapping coefficients will also satisfy
transitivity and scale invariance. Finally, the same argument will
show that although the factor loadings b1j and b2j will vary from
tudy to study, their ratio will not.
The common factor model (1) has not, as far as we know, been
pplied in the context of mapping between disease-specific and
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Fig. 1 – Comparison of criteria used by four regressions: OLS
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180 V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4ship with test theory. They are also important for estimating the
mapping parameters from data in practice.
Reparameterization of the common factor model in terms of
reliability and responsiveness
The reliability of the Y score is defined as a ratio of the variance in
the depression factor to the total variance in the observed score,
namely,	Yj  b1j
2 ⁄b1j2  h12. Note that reliability depends on the vari-
ation in the “true” test scores, and thus on the study population j.
We remarked earlier that the loadings h represented any factor
that affected the reproducibility of the score, which is determined
primarily by its TRR. The reliability of the generic QOL score can be
defined similarly as 	Qj  b2j2  fj2⁄b2j2  fj2  h22.
For the purposes of studying the relationship between a QOL
score and a depression score, however, a measure that is of more
direct interest is theproportionof the total variance that is accounted
for by the between-patient variance in “true” depression scores. This
could be called the responsiveness of the QOL test to depression:
	Qj
D  b2j
2 ⁄ b2j2  fj2h22 (2)
(As an aside it is worth pointing out that exactly the same consid-
erations apply with physician-rated scales, such as the Hamilton
[15] and Montgomery-Asberg [16] depression scales. Here the TRR
is themain component of reproducibility. If each patientwas rated
by a different clinician, then interrater reliability would be an ad-
ditional contributor to measurement error. If all are rated by the
same clinician, then interrater variation does not contribute to the
variance of test scores. Usually, a small number of raters are used,
in which case a suitable adjustment can be made to estimate the
overall measurement error in the study).
Estimating mapping coefficients from a cohort study with
external data on reliability
Under the factor model (1), and suppressing the study-specific in-
dex j, the observed pairs of scores (Yi, Qi) have the following cova-
iance structure:
b12h12 b1b2b1b2 b22 f 22 h22 (3)
The mapping coefficient is related to these terms as follows:
Y→Q
b2
b1
 signb1b2
(b2
2 f 2h2
2)	Q
D
(b12h12)	Y
(4)
he covariance matrix can be estimated from the sample vari-
nces and covariance. Let SYY 
1
n1

iYi  Y 2, SQQ 
1
n1
iQi  Q 2, and SYQ 
1
n1

iYi  Y Qi  Q . It is not possible, how-
ever, to estimate the mapping coefficient from the sample alone,
and external data are required in addition. Note that the correla-
tion between the Y andQ scores is related to the reliability of Y and
the responsiveness of Q to depression:
	YQ
2 
b1
2b2
2
(b1
2h1
2)(b2
2 f 2
2h2
2)
	Y	Q
D (5)
The formula shows that the two tests would be perfectly corre-
lated, except for the measurement error in each test, assumed to
be independent, and the lack of validity of Q. Equation (5) gives us
a method for estimating the mapping coefficient by using external
information on the reliability of the Y score, 	^Y. By using (5), we can
hen derive an estimate 	^Q
D 	^YQ
2 ⁄	^Y by using the sample correlation.
Then, Y→Q  b2⁄b1 can be estimated by
ˆD ˆ
ˆ
Y→Q sign(SYQ)	QSQQ
	ˆYSYY

	YQ
	ˆY
SQQSYY (6) tThis is the GM regression, ˆY→Q
GM  signSYQSQQ ⁄ SYY, “adjusted” by
the estimates of theproportionsof thevarianceattaching to “depres-
sion.” Note, however, that the OLS estimate ˆY→Q
OLS  SYQ ⁄ SYY and the
sample correlation is SYQ ⁄SYYSQQ. From this it can be shown that
stimate (6) is also equivalent to ˆY→Q
OLS ⁄ 	^Y, which can be recognized as
he OLS estimate with the standard “correction” for attenuation due
oerror in covariates.Thus, theestimatedmapping (6),whichhas the
equired coherence properties, can be seen as an adjusted form of
M regression, or, equally, an adjusted form of OLS regression.
Finally, based on the transitivity assumption, a mapping be-
ween two generic QOL scores can be derived from the quotient of
appings from a depression score onto each QOL scale:
ˆ
Q1→Q2
ˆY1→Q2
ˆY→Q1
(7)
Note, however, that this is not a general-purpose mapping from
one scale to the other: it is specifically a mapping for the depres-
sion components of the two scales, and would be relevant only for
mapping between the effects of treatment for depression on the
two scales.
Alternative method of estimating mappings when there are
more than two instruments
The previous section shows how to estimate coherent mappings
from data on one DSM and one generic QOL. In a situation in which
we had two generic QOLmeasures, we could carry out this process
on both independently, and, as we show in (7), derive themapping
between the QOL measures by using the transitivity property. We
now use the same factor loading model to consider how to esti-
mate coherent mappings from cohort data on more than two in-
strumentswithout the use of external data. Suppose again thatwe
have one disease-specific and two generic QOL instruments, for
example, BDI, the EQ-5D questionnaire, and SF-12M. We are justi-
fied in considering theMental Components summary of SF-12 as a
generic measure because it includes both “depression” and “non-
depression” components, and thus serves for this illustration.
Yi a0 b0yih01i
Q1i a1 b1yi f 1x1ih11i,
Q2i a2 b2yi f 2x2ih22i
where x1i, x2i,yi, 1i, 2i indN(0, 1)
(8)
Note that the “nondepression” components of Q1 and Q2, namely,
1i and x2i, are assumed to be independent, an issue to which we
eturn later. Our task now is to estimate the three coherent map-
ings simultaneously: b1⁄b0 for Y¡ Q1, b2⁄b0 for Y¡ Q2, and b2⁄b1 for
1 ¡ Q2. Previously, we used an external estimate of 	Y. But note
he relationship:
Y 	YQ1	YQ2
	Q1Q2
 (9)
Because we have internal estimates of the three correlation coeffi-
cients, a set of internal estimates can be derived, which do not
require external information:
ˆY→Q1 sign(	ˆYQ1)	ˆQ1Q2
	ˆYQ2
SQ1Q1SYY
ˆY→Q2 sign(	ˆYQ2)	ˆQ1Q2
	ˆYQ1
SQ2Q2SYY
ˆQ1→Q2
	ˆYQ2
	ˆYQ1
SQ2Q2SQ1Q1
(10)
ote that the mapping between the QOL measures is identical to
he one derived from the disease-specific¡ QOLmappings above,
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181V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4based on external information, because the Q1, Q2 correlation
erms cancel out. We thus have two sets of three “coherent” map-
ings, such that one of the mappings is identical in both sets,
hile the two others are not.
Estimating test reliability from external information
The use of external estimates of test reliability immediately cre-
ates an important problem in that estimates of reliability are
highly variable, depending as they do on the degree of between-
individual variation in the “true” test scores. This, in turn, depends
on the population being sampled. Our strategy here is based on the
view that the study-specific reliabilities reported in the literature
are samples from a distribution.We therefore attempt to estimate
this distribution from the literature, and we interpret it as a pre-
dictive distribution in the sense that any sample drawn from it
could reasonably represent the true reliability in a randomly se-
lected cohort study or trial, such as the study used as an illustra-
tion in this article. This procedure is intended to fairly capture the
considerable uncertainty in the external reliability estimates.
As BDI is a patient-reported outcome, we have assumed that
TRR is the main determinant of reproducibility, and this justifies
our use of TRT to approximate themeasurement error term in our
factor models. For this purpose, we have used the range of values,
0.60 to 0.90 for TRT assessments less than 3 weeks apart, reported
by Beck et al. [17]. We have taken these to be estimates of the 95%
redible interval for studies on “depressed” patients, and following
common practice in psychometric meta-analysis [18,19], we
ave assumed that the Fisher transforms of the reliabilities are
ormally distributed:
ˆ 
1
2
log1 	ˆ1	ˆ  and 	ˆ  e2zˆ 1e2zˆ 1 (11)
vih Simulating in this way generates a mean of the distribution of
reliability values of 0.782, within 0.60 to 0.90 as the 2.5 and 97.5
percentiles.
Results
The IPCRESS trial [20] gathered data on 181 individuals with com-
lete data at pretreatment baseline on the BDI, the SF-12M, and
he EQ-5D questionnaire, andwe use this to illustrate our outcome
ariables {Yi, Q1i, Q2i, i 1, . . ., 181}. The sufficient statistics,means,
SDs, and correlations are shown in Table 1.
Figure 2 shows the scatter plots of the centered data and the
estimated regression lines for each pair of variables 1) from BDI to
the EQ-5D questionnaire, 2) from BDI to SF-12M, and 3) from SF-
12M to the EQ-5D questionnaire. The OLS, inverse-OLS, and GM
regressions are contrasted with the coherent mappings based on
the common factor model. The departure from the invertability
requirement in the OLS estimates is marked, amounting to two-
fold difference in slope. The DSM¡ QOLmappings from the com-
Table 1 – Summarized statistics for the IPCRESS data, base
Test Mean SD (95% CI)
BDI 33.31 8.651 (7.82–9.40)
SF-12M 23.64 7.962 (6.89–8.98)
EQ-5D questionnaire 0.679 0.210 (0.19–0.23)
Note. Confidence intervals are estimated from bootstrap resampling f
matrix.
BDI, Beck Depression Inventory; CI, confidence interval; EQ-5D, EuroQon factormodel, however, tend to be closer to the OLS estimates than to the GM estimates, because compared with the generic
easures, a relatively high proportion of the variance in DSMs is
ue to patient variation in “depression.” For the depression-re-
ated mapping between the two generic measures, the coherent
apping is quite close to the GM estimate, because in this case an
pproximately equal proportion of the total score variances is due
o patient variance in depression. Put another way, the EQ-5D
uestionnaire and SF-12M are approximately equal in their re-
ponsiveness to depression.
Uncertainty of estimation can be examined in Table 2, based on
ootstrap resampling from the data and the sampling of reliability
stimates from a presumed population of studies. Note that the
wo sets of estimates from BDI ¡ the QOL scales, those based on
n external estimate of reliability and those based on internal
ata, are adequately close in relation to their credible intervals.
he internal estimates of the DSM¡QOLmappings were lower in
3% of the simulations, corresponding to a two-sided P value of
.46 to “test” the null hypothesis of no difference between the two
stimates. This provides some support, although only weak sup-
ort, for the common factor model and on our external estimates
f BDI reliability. The precision of the estimates, based on the
oderate data set, are of some interest also: when external evi-
ence is used for the reliability of BDI, the DSM¡ QOL mappings
have standard errors that are approximately 13% of the central
estimate. This is reduced to 7% or less when internal estimates are
used.
Discussion
Our starting position is that mappings between mean treatment
effects must be invertible, transitive, and scale invariant in order
to be considered coherent. Similar properties have been claimed
for the mappings described in the “test equating” and test “link-
ing” literature [22–24], although it is oriented to the much more
demanding application of mapping between individual scores
rather than mean treatment effects. GM regression has these
properties, but these are shared by neither OLS norOR regressions.
GM regression, however, has this property only under very special
circumstances, namely, when the ratio of variance in the target
attribute to total variance is precisely the same for both variables.
We therefore developed a common factor model from which we
could derive expressions for coherentmapping coefficients, what-
ever the reliability and responsiveness of the DSM and generic
QOL instruments happened to be. These coefficients could be seen
as “adjusted” OLS or GM regression estimators.
The relationships between these constructs are interesting and
revealing for different reasons. The GM estimate signSYQSQQ⁄SYY
has to be adjusted because the mapping is determined not by the
ratio of observed variances but also by the ratio of those proportions
of the variances that are attributable to “depression,” what we
have called responsiveness to depression. The relationship with
the standard OLS estimator, S /S , is also of interest, because it
181 patients with complete data at baseline.
Sample correlation (95% CI)
DI SF-12M EQ-5D
1 0.375 (0.51 to 0.22) 0.425 (0.54 to 0.30)
* 1 0.251 (0.12 to 0.38)
* * 1
the data. Here, * denotes the lower triangular entries in a symmetric
e-dimensional; SF-12 M, SF-12 Mental Components Summary.d on
B
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182 V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4mappings based on the common factor model by a factor equal to
the reproducibility of theDSM instrument. For patient-reported out-
comes such as BDI, this can be represented best by the TRR. For
clinician-reported outcomes, such as the Hamilton or MADRS
scales in the field of depression, both TRR and interrater reliability
hould be taken into account, although the effect of the latter on
eproducibility will be small as long as the number of different
aters used is relatively small.
As a further illustration of how the present proposals can be
pplied in other areas, consider the mapping from Mini-Mental
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eometric mean; OLS, ordinary least squares; SF-12 M, SF-1tate Examination to the EQ-5D questionnaire in patients withAlzheimer’s disease. A literature review of the psychometric prop-
erties of the Mini-Mental State Examination posted on the Stroke
Engine Web site (http://strokengine.ca/) suggests a TRR (at 2
months) of around 0.75. Given this estimate, OLS would underes-
timate the mapping coefficient, and hence treatment effects on
the EQ-5D questionnaire, by about a factor of 1.33.
If cohort data are available on one DSM and one generic QOL, a
coherentmapping can be estimated onlywith external data on the
reliability of the DSM score. If data on one DSM and two generic
QOL measures are available, coherent estimates can be obtained
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183V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4DSM and two QOL scales, that the two sets of estimates were sat-
isfactorily close, certainly well within the confidence limits im-
posed by the data at hand. The consistency of the two estimates is
encouraging but provides only weak support for the factor model.
The common factor model represents a characterization of
testing instruments that accords with psychometric theory and
structural equation modeling going back over many years
[14,18,25], although the idea of applying this to DSM and generic
QOL measures is probably new. At the same time, it should be
conceded that the common factor model presented here is per-
haps the simplest that could have been proposed andmakesmany
assumptions that deserve closer scrutiny. For example, we have
assumed that the measurement error terms in all the tests are
independent, that the DSM, BDI, is a “pure” test of depression
except for reproducibility error, and also that there is no correla-
tion between the “nondepression” components of the two QOL
measures.We have also assumed that depression is a unitary con-
cept and that treatments for depression have no effect on the
orthogonal “nondepression” components. Each of these assump-
tions can be challenged, and each needs to be considered afresh in
every application.
First, a check on the independence assumptions is provided by
the partial correlation between the EQ-5D questionnaire and SF-
12M conditional on BDI. This is 0.10 but with a credible interval
that includes zero (95% confidence interval 0.037 to 0.24). A pos-
itive partial correlation, not unlikely on this evidence, could sug-
gest nonindependence in either measurement error or the “non-
depression” components of the QOL scores. Second, depression is
probably not a unitary construct to the extent that factor analysis
pplied to the individual item scores of several depression tests
as suggested three or more distinct factors [19]. This is not nec-
essarily a fatal flaw in the model, as long as we can assume that
the standardized treatment effect is approximately the same on
each of the putative “dimensions” of depression. This restriction
does imply, however, that additional assumptions may be re-
quired to apply the current model to DSMs that are deliberately
constructed to be sensitive to a wider range of constructs. It re-
mains an issue for further research to explore the empirical ade-
quacy of assumptions made here, and sensitivity of the estimated
mapping coefficients to deviations from them.
Another set of simplifying assumptions we have relied on relate
to the linearity, cardinality, and scaling of test results on the various
instruments. The tests are vulnerable to floor and ceiling effects to
different degrees, and the EQ-5D questionnaire is particularly prob-
lematic in termsof its scaleand“censored”values.Ourassumption is
that the approachwehave adopted tomapping could still be applied
to more sophisticated treatments of the test results [21].
The linearity assumption deserves special mention as investi-
Table 2 – Estimates of coefficients from standard regressio
model, based on data from the IPCRESS trial [21].
Estimation method BDI¡ EQ-5D
ˆ (95 % CI), SE
GM regression 0.0243 (0.027 to 0.022), 0.00
OLS regression 0.0103 (0.013 to 0.007), 0.00
Inverse OLS regression 0.0586 (0.084 to 0.036), 0.01
Common factor model, external
information on ˆ
0.0134 (0.018 to 0.0087), 0.0
Common factor model, internal
information on ˆ
0.0163 (0.027 to 0.0079), 0.0
Note. The 95% credible intervals and standard errors from bootstrap
external data.
BDI, Beck Depression Inventory; EQ-5D, EuroQol five-dimensional; G
Components Summary.gators not infrequently consider adding quadratic or cubic termsto mapping equations, although the improvement in fit is usually
verymodest [5]. It should be emphasized, though, that whenmap-
ping mean treatment effects the inclusion of nonlinear terms
would be a serious mistake, because the distance from the inter-
cept is not generally defined. If it is considered that nonlinearity
exists, then separate linear mapping coefficients should be esti-
mated for different parts of the scale, for example, for “mild,” “mod-
erate,” and “severe.” These comments clarify that mapping mean
treatment effects, which is usually the only data available in an evi-
dence synthesis context, is a somewhat approximate procedure.
It must be conceded that the need for external data on TRR
creates difficulties for the use of the common factor model. This is
because an examination of the available literature tends to reveal
a large number of estimates, spanning a relatively wide range,
often based on small samples in poorly characterized populations.
The greatest difficulty, perhaps, lies in the lack of clarity about
what time intervals should be used for assessments of TRR. It is
therefore essential that uncertainty regarding the TRR, and its ca-
pacity to vary with context, is recognized. However, we would
argue that any additional uncertainty inmapping coefficients aris-
ing from the methods we propose is to be preferred to systematic
underestimation of themapping that would result from the use of
OLS regression.
The literature on “test equating” [22–24], mentioned above, has
been mainly oriented to ensuring that different educational at-
tainment tests can be equated or aligned, to ensure fair assess-
ments of pupils tested with different instruments. The linearity
assumption of the common factor model makes it clearly unsuit-
able and oversimplistic for this much more demanding applica-
tion. Methods described in this literature, including item response
theory [26] and percentile matching, have been used to map be-
tween depression instruments [19,27,28] but have not been used
for scales as disparate as depression and the EQ-5D questionnaire.
Indeed, at first sight it would appear that item response theory
could not be applied as generic QOL measures are, by definition,
designed to be multidimensional. By the same token, we would
emphasize that themethods proposed here are suited tomapping
between the mean effects that can be attributed to causal influ-
ences on “depression,” but it should not be assumed that they will
necessarily generalize to differences between groups or differ-
ences over time.
The use of the common factor model, and the demonstration
that, in certain circumstances, there may be a choice between
estimates that are “internal” to a data set, or estimates that rely in
part on external information, raises a series of questions about
how to combine multiple sources of evidence on mapping. Accep-
tance of the symmetry and transitivity properties means, for ex-
ample, that although there are M(M  1)/2 mappings between M
dels and coherent estimates from the common factor
BDI¡ SF-12M
ˆ (95 % CI), SE
SF-12M¡ EQ-5D
ˆ (95 % CI), SE
0.921 (1.06 to 0.79), 0.070 0.0265 (0.022–0.031), 0.0025
0.345 (0.49 to 0.20), 0.073 0.00663 (0.0028–0.0105), 0.0019
2.59 (4.49 to 1.71), 0.722 0.126 (0.0690–0.235), 0.549
0.446 (0.59 to 0.35), 0.062 0.0316 (0.018–0.055), 0.0095
0.541 (0.62 to 0.46), 0.041 0.0316 (0.018–0.055), 0.0095
pling from data, and sampling from distribution of ˆ derived from
eometric mean; OLS, ordinary least squares; SF-12 M, SF-12 Mentaln mo
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184 V A L U E I N H E A L T H 1 6 ( 2 0 1 3 ) 1 7 7 – 1 8 4rameters. It follows that in most cases there will be considerable
redundancy in the information available to estimate parameters.
Multiparameter evidence synthesis [29] approaches should make
it possible to incorporate information from different cohorts, each
looking a different subset of the M tests, as well as external esti-
ates of reliability, correlation, variance, and responsiveness.
his could provide mapping estimates that are more precise and
ore robust to changes in the evidence sources and could lead to
tronger assessments of the validity of the model and eventually
o better models.
Many of the mappings now used in CEA are considerably more
omplex than the simple univariatemappings of the typewe have
ocused on. In addition, as mentioned above, single DSMs are of-
en designed to be sensitive to a wide spectrum of functional,
linical, and psychological constructs, and further research is
eeded on how the common factor model might need to be ex-
ended to this case. Moreover, multivariate regressions are being
sed, inwhich the EQ-5D questionnaire or other generic QOLmea-
ure is regressed against more than one disease-specific variable.
his multivariate mapping is then applied to aggregated treat-
ent effects on several DSMs to obtain a mapping into a generic
cale. This is common inmultifaceted conditions such as psoriatic
rthritis or ankylosing spondylitis, where disease-specific assess-
ents of disease progression in different organ systems, func-
ional performance, and pain measures are all sensitive to
hanges due to treatment, andwhich all appear to reflect different
spects of the disease. Similarly, in Alzheimer’s disease,mappings
ased on cognitive, functional, and behavioral scales are used.
We are now undertaking further research to define coherence
roperties formultivariate functional relationships, and to extend
he ideas on the estimation of univariatemappings presentedhere
o themultivariate case. However, it seems inevitable that the lack
f symmetry in the way that functional relationships between
cales are considered in OLS, as well as the failure to deal with
easurement error, indicates that OLS regressionmust systemat-
cally underestimate mapping coefficients in multivariate and
nivariate cases alike.
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